Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chisholm Venture Partners is a venture capital firm that specializes in early-stage investments within the life sciences and healthcare sectors. The firm focuses on identifying and nurturing innovative biotechnologies, pharmaceutical platforms, and medical device companies. It is known for its hands-on investment approach, where partners often take active leadership or advisory roles to guide the strategic direction of portfolio companies. The leadership team comprises seasoned industry executives with deep expertise in drug discovery, clinical development, and corporate strategy. Chisholm Venture Partners has historically invested in companies such as Bionomics, Archemix, and Pherin Pharmaceuticals. By leveraging its extensive network and technical knowledge, the firm aims to accelerate the transition of scientific breakthroughs into viable commercial products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chisholm Venture Partners.